Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH)

Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH)

Background: Bictegravir (BIC), a recently introduced integrase inhibitor, is available in a single tablet regimen with tenofovir alafenamide (TAF) and emtricitabine (FTC) (BIC-STR). This study aimed to describe a real-life experience with BIC-STR. Methods: We retrospectively analyzed the data of peo...

Full description

Bibliographic Details
Main Authors: Anna Gidari, Sara Benedetti, Sara Tordi, Anastasia Zoffoli, Debora Altobelli, Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Daniela Francisci
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Infectious Disease Reports
Subjects:
HIV
bictegravir
integrase inhibitors
real-life
antiretroviral
Online Access:https://www.mdpi.com/2036-7449/15/6/69

Similar Items

Similar Items